Arcus Biosciences, Inc.

RCUS

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001724521

SEC filings (opens in a new tab)

In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Arcus Biosciences, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of RCUS: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	187	2	186	+1
Shares	53.3M	32.1K	83.9M	+30.6M (+57.4%)
Value	$815.7M	$489.7K	$1.25B	+$434.4M (+53.3%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Arcus Biosciences, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to RCUS in Q4 2024
Institution	Shares	Value	% of portfolio
Gilead Sciences, Inc.	30,061,124	$447.6M	28.86%
Boxer Capital Management, LLC	1,602,200	$23.9M	2.03%
Braidwell LP	802,100	$11.9M	0.35%
Jacobs Levy Equity Management, Inc	465,304	$6.93M	0.02%
Adage Capital Partners GP, L.L.C.	443,000	$6.60M	0.01%
Readystate Asset Management LP	351,356	$5.23M	0.22%
Diadema Partners LP	165,965	$2.47M	2.78%
Connor, Clark & Lunn Investment Management Ltd.	64,043	$953.6K	0.00%
ExodusPoint Capital Management, LP	60,193	$896.0K	0.01%
Persistent Asset Partners Ltd	50,213	$647.7K	0.55%
Raymond James Financial Inc	35,662	$531.0K	0.00%
Tema ETFs LLC	22,233	$331.0K	0.14%
Jump Financial, LLC	17,244	$256.8K	0.01%
Verition Fund Management LLC	15,337	$228.4K	0.00%
KLP Kapitalforvaltning AS	13,900	$207.0K	0.00%
Police & Firemen's Retirement System of New Jersey	12,248	$182.4K	0.00%
Axq Capital, LP	10,761	$160.2K	0.07%
Altfest L J & Co Inc	10,509	$156.5K	0.02%
PEAK6 LLC	10,000	$148.9K	0.01%
R Squared Ltd	1,720	$25.6K	0.02%
Aster Capital Management (DIFC) Ltd	192	$2.86K	0.00%
Creative Planning	79	$1.18K	0.00%
IFP Advisors, Inc	65	$1.03K	0.00%
SBI Securities Co., Ltd.	21	$313	0.00%
Skopos Labs, Inc.	1	$15	0.00%

Sold out (24)

Institutions that held Arcus Biosciences, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of RCUS in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Boxer Capital, LLC	1,602,200	$24.5M
Walleye Capital LLC	238,544	$3.65M
Panagora Asset Management Inc	112,829	$1.73M
Dynamic Technology Lab Private Ltd	35,053	$536.0K
EntryPoint Capital, LLC	26,389	$403.5K
Allianz Asset Management GmbH	24,500	$374.6K
Y-Intercept (Hong Kong) Ltd	23,581	$360.6K
Laurion Capital Management LP	20,263	$309.8K
Corton Capital Inc.	15,789	$241.4K
D. E. Shaw & Co., Inc.	13,501	$206.4K
Catalyst Funds Management Pty Ltd	4,100	$62.7K
Aquatic Capital Management LLC	3,600	$55.0K
Point72 Hong Kong Ltd	3,100	$47.4K
Ronald Blue Trust, Inc.	376	$5.73K
Macroview Investment Management LLC	115	$1.76K
Bessemer Group Inc	70	$1.00K
Smartleaf Asset Management LLC	21	$323
Parkside Financial Bank & Trust	15	$230
Huntington National Bank	13	$199
Capital Performance Advisors LLP	10	$153
JFS Wealth Advisors, LLC	7	$108
Mendota Financial Group, LLC	7	$108
SJS Investment Consulting Inc.	5	$77
Hemington Wealth Management	1	$0

Not filed for Q4 2024 yet (2)

Institutions that held Arcus Biosciences, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCUS in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
ClariVest Asset Management LLC	17,092	$260.3K
PEAK6 Investments LLC	15,000	$229.3K